US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Personalis

18.38

+1.508.89%

Post-market: 18.470.0876+0.48%19:55 EDT

Volume:8.00M

Turnover:144.91M

Market Cap:1.97B

PE:-16.75

High:18.89

Open:16.66

Low:16.62

Close:16.88

52wk High:18.89

52wk Low:4.65

Shares:107.00M

Float Shares:72.63M

Volume Ratio:1.56

T/O Rate:11.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0976

EPS(LYR):-0.9107

ROE:-50.32%

ROA:-25.03%

PB:8.36

PE(LYR):-20.18

Loading ...

Overview Company News Filings

Personalis Cfo/coo Aaron Tachibana Disposes of 4,982 Common Shares for $69,748

Personalis CEO Christopher M. Hall Disposes of 100,000 Common Shares Worth $1.32 Million

Personalis (PSNL) Stock Could Be 10% Undervalued After ASCO Cancer Data

Simply Wall St.

How Investors May Respond To Personalis (PSNL) CE Mark Win For Its MRD Blood Collection Kits

Simply Wall St.

A Look At Personalis (PSNL) Valuation After New ASCO Data On NeXT Personal MRD Platform

Simply Wall St.

Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing

MT Newswires Live

Personalis blood collection kits win EU CE-IVD mark under IVDR

Can Personalis (PSNL) Turn NeXT Personal’s Multi‑Tumor MRD Data Into Durable Competitive Advantage?

Simply Wall St.

Personalis CFO, COO Aaron Tachibana disposes of common shares worth $480,400

Personalis' Cancer Monitoring Tool Shows Early Detection of Relapse

MT Newswires Live

Personalis NeXT Personal MRD test posts 100% sensitivity for colorectal cancer relapse in VICTORI study at ASCO 2026

Personalis CEO Christopher M. Hall disposes of common shares worth $1,101,800.18

Personalis CFO, COO Aaron Tachibana disposes of common shares valued at $449,248.42

Personalis NeXT Personal ctDNA assay posts 100% longitudinal sensitivity for colorectal cancer recurrence in VICTORI study

Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)

Personalis Inc - CMS Expands Medicare Coverage for Personalis Next Personal Test in Breast Cancer Monitoring - SEC Filing

THOMSON REUTERS

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Personalis (PSNL)

Personalis NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid

MT Newswires Live

Personalis secures fourth Medicare coverage decision for NeXT Personal

Personalis cites PREDICT-DNA study supporting NeXT Personal monitoring in breast cancer NAT

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PSNL/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSNL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSNL\",,,,,undefined,":{"symbol":"PSNL","market":"US","secType":"STK","nameCN":"Personalis","latestPrice":18.38,"timestamp":1787342400000,"preClose":16.88,"halted":0,"volume":8001823,"hourTrading":{"tag":"盘后","latestPrice":18.4676,"preClose":18.38,"latestTime":"19:55 EDT","volume":21779,"amount":400968.5526,"timestamp":1787356553172,"change":0.0876,"changeRate":0.004766,"amplitude":0.017715},"delay":0,"changeRate":0.08886255924170616,"floatShares":72626708,"shares":107000000,"eps":-1.097591,"marketStatus":"Market Closed","change":1.5,"latestTime":"08-21 16:00:00 EDT","open":16.655,"high":18.89,"low":16.62,"amount":144912838.489894,"amplitude":0.134479,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.097591,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1561003200000,"exchange":"NASDAQ","adjPreClose":16.88,"preHourTrading":{"tag":"盘前","latestPrice":16.7,"preClose":16.88,"latestTime":"09:29 EDT","volume":28695,"amount":477765.924915,"timestamp":1787318999999,"change":-0.18,"changeRate":-0.010664,"amplitude":0.024887},"postHourTrading":{"tag":"盘后","latestPrice":18.4676,"preClose":18.38,"latestTime":"19:55 EDT","volume":21779,"amount":400968.5526,"timestamp":1787356553172,"change":0.0876,"changeRate":0.004766,"amplitude":0.017715},"volumeRatio":1.5597784777227224,"optionData":{"bulkOrders":[{"symbol":"PSNL","call":true,"expireDate":1799989200000,"strike":"20.0","timestamp":1787340710366,"price":2,"volume":2500,"amount":500000,"type":"-"}]},"impliedVol":0.6922,"impliedVolPercentile":0.1474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSNL\",,,,,undefined,":{"symbol":"PSNL","floatShares":72626708,"roa":"-25.03%","roe":"-50.32%","lyrEps":-0.910685,"volumeRatio":1.5597784777227224,"shares":107000000,"dividePrice":0,"high":18.89,"amplitude":0.134479,"preClose":16.88,"low":16.62,"week52Low":4.6524,"pbRate":"8.36","psRate":"28.23","week52High":18.89,"institutionHeld":0,"latestPrice":18.38,"eps":-1.097591,"divideRate":0,"volume":8001823,"delay":0,"ttmEps":-1.097591,"open":16.655,"prevYearClose":7.96,"prevWeekClose":14.04,"prevMonthClose":12.66,"prevQuarterClose":13.4,"fiveDayClose":14.04,"twentyDayClose":11.78,"sixtyDayClose":9.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSNL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"PSNL","fiscalQuarterEnding":"2026/06","expectedEps":-0.25,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-0.3},{"market":"US","date":"2026-05-07","symbol":"PSNL","fiscalQuarterEnding":"2026/03","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-02-26","symbol":"PSNL","fiscalQuarterEnding":"2025/12","expectedEps":-0.31,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.26},{"date":"2026-01-08","symbol":"PSNL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1767862800000,"name":null,"time":"Pre-MKt","dateTimestamp":1767848400000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"PSNL","fiscalQuarterEnding":"2025/09","expectedEps":-0.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSNL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSNL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.2,"hold":0.4,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PSNL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PSNL","date":"2026-08-21","current":-16.745764,"percent":0.035159,"low":-19.82708,"twenty":-9.399353,"median":-3.577917,"eighty":-0.867091,"high":-0.404396,"avg":-5.054939,"sd":4.792174,"marketCap":1802781839},"quantilePoints":[{"date":"2021-08-27","current":-18.200606,"twenty":-31.707879,"median":-22.415008,"eighty":-14.44116,"marketCap":914453024},{"date":"2021-09-03","current":-19.82708,"twenty":-31.687673,"median":-22.346009,"eighty":-14.49083,"marketCap":996171993},{"date":"2021-09-10","current":-19.07572,"twenty":-31.665779,"median":-22.148867,"eighty":-14.508515,"marketCap":958421383},{"date":"2021-09-17","current":-19.782883,"twenty":-31.656164,"median":-21.951725,"eighty":-14.55021,"marketCap":993951369},{"date":"2021-09-24","current":-17.36085,"twenty":-31.638663,"median":-21.793563,"eighty":-14.580876,"marketCap":872261166},{"date":"2021-10-01","current":-17.184059,"twenty":-31.619391,"median":-21.633238,"eighty":-14.626636,"marketCap":863378669},{"date":"2021-10-08","current":-16.494575,"twenty":-31.569648,"median":-21.489061,"eighty":-14.644348,"marketCap":828736932},{"date":"2021-10-15","current":-17.626036,"twenty":-31.516003,"median":-21.4293,"eighty":-14.664665,"marketCap":885584911},{"date":"2021-10-22","current":-16.750922,"twenty":-31.446778,"median":-21.335657,"eighty":-14.709171,"marketCap":841616552},{"date":"2021-10-29","current":-17.343171,"twenty":-31.301431,"median":-21.26711,"eighty":-14.753543,"marketCap":871372916},{"date":"2021-11-05","current":-15.782689,"twenty":-31.246253,"median":-21.212444,"eighty":-14.754971,"marketCap":921204020},{"date":"2021-11-12","current":-14.110047,"twenty":-31.176582,"median":-21.150896,"eighty":-14.664665,"marketCap":823575203},{"date":"2021-11-19","current":-11.470647,"twenty":-31.117875,"median":-21.054147,"eighty":-14.564258,"marketCap":669518721},{"date":"2021-11-26","current":-10.73407,"twenty":-30.991792,"median":-21.000517,"eighty":-14.499351,"marketCap":626526215},{"date":"2021-12-03","current":-9.391352,"twenty":-30.954532,"median":-20.926589,"eighty":-14.272133,"marketCap":548154458},{"date":"2021-12-10","current":-10.104911,"twenty":-30.796635,"median":-20.71959,"eighty":-14.156264,"marketCap":589803449},{"date":"2021-12-17","current":-11.217449,"twenty":-30.685161,"median":-20.630876,"eighty":-14.087518,"marketCap":654740047},{"date":"2021-12-23","current":-11.017959,"twenty":-30.246012,"median":-20.512591,"eighty":-13.968229,"marketCap":643096243},{"date":"2021-12-31","current":-10.948905,"twenty":-30.059123,"median":-20.349251,"eighty":-13.825657,"marketCap":639065696},{"date":"2022-01-07","current":-9.913094,"twenty":-29.981199,"median":-20.108451,"eighty":-13.775093,"marketCap":578607484},{"date":"2022-01-14","current":-9.399025,"twenty":-29.928617,"median":-19.956055,"eighty":-13.721129,"marketCap":548602297},{"date":"2022-01-21","current":-7.803109,"twenty":-29.918874,"median":-19.808308,"eighty":-13.585955,"marketCap":455451866},{"date":"2022-01-28","current":-7.956562,"twenty":-29.877673,"median":-19.756332,"eighty":-13.353358,"marketCap":464408638},{"date":"2022-02-04","current":-8.83892,"twenty":-29.811855,"median":-19.697872,"eighty":-13.273998,"marketCap":515910078},{"date":"2022-02-11","current":-8.746848,"twenty":-29.746302,"median":-19.625453,"eighty":-13.144564,"marketCap":510536015},{"date":"2022-02-18","current":-7.411803,"twenty":-29.658908,"median":-19.575153,"eighty":-13.073494,"marketCap":432612097},{"date":"2022-02-25","current":-7.084401,"twenty":-29.613376,"median":-19.546242,"eighty":-12.95771,"marketCap":462087120},{"date":"2022-03-04","current":-6.140273,"twenty":-29.600919,"median":-19.489865,"eighty":-12.788865,"marketCap":400505471},{"date":"2022-03-11","current":-5.768136,"twenty":-29.571929,"median":-19.393943,"eighty":-12.639003,"marketCap":376232412},{"date":"2022-03-18","current":-6.023119,"twenty":-29.536457,"median":-19.312078,"eighty":-12.590719,"marketCap":392863952},{"date":"2022-03-25","current":-5.402889,"twenty":-29.512381,"median":-19.14537,"eighty":-12.483587,"marketCap":352408854},{"date":"2022-04-01","current":-6.047658,"twenty":-29.382839,"median":-19.089845,"eighty":-12.470047,"marketCap":394464526},{"date":"2022-04-08","current":-5.223292,"twenty":-29.178413,"median":-18.956505,"eighty":-12.397584,"marketCap":340694447},{"date":"2022-04-14","current":-4.779936,"twenty":-29.088533,"median":-18.89009,"eighty":-12.269774,"marketCap":311776086},{"date":"2022-04-22","current":-4.094119,"twenty":-29.035348,"median":-18.828213,"eighty":-11.86367,"marketCap":267042995},{"date":"2022-04-29","current":-3.879368,"twenty":-28.96283,"median":-18.79718,"eighty":-11.678705,"marketCap":253035664},{"date":"2022-05-06","current":-2.916465,"twenty":-28.890093,"median":-18.743612,"eighty":-11.414586,"marketCap":236324036},{"date":"2022-05-13","current":-2.81551,"twenty":-28.718667,"median":-18.713299,"eighty":-11.156067,"marketCap":228143588},{"date":"2022-05-20","current":-2.484603,"twenty":-28.67061,"median":-18.563027,"eighty":-11.02524,"marketCap":201329899},{"date":"2022-05-27","current":-2.568732,"twenty":-28.579732,"median":-18.398366,"eighty":-10.88967,"marketCap":208146939},{"date":"2022-06-03","current":-2.14248,"twenty":-28.497441,"median":-18.332161,"eighty":-10.84916,"marketCap":173607272},{"date":"2022-06-10","current":-2.209783,"twenty":-28.475476,"median":-18.253643,"eighty":-10.70338,"marketCap":179060904},{"date":"2022-06-17","current":-1.834007,"twenty":-28.458863,"median":-18.162544,"eighty":-10.488545,"marketCap":148611461},{"date":"2022-06-24","current":-2.243434,"twenty":-28.429817,"median":-18.115189,"eighty":-10.410847,"marketCap":181787720},{"date":"2022-07-01","current":-1.906919,"twenty":-28.395742,"median":-17.970778,"eighty":-10.316677,"marketCap":154519562},{"date":"2022-07-08","current":-2.26026,"twenty":-28.383652,"median":-17.882382,"eighty":-10.238416,"marketCap":183151127},{"date":"2022-07-15","current":-2.271477,"twenty":-28.3666,"median":-17.744222,"eighty":-10.092635,"marketCap":184060066},{"date":"2022-07-22","current":-2.10322,"twenty":-28.354794,"median":-17.626036,"eighty":-9.973134,"marketCap":170425987},{"date":"2022-07-29","current":-2.069568,"twenty":-28.295083,"median":-17.555319,"eighty":-9.885428,"marketCap":167699171},{"date":"2022-08-05","current":-2.432658,"twenty":-28.246574,"median":-17.36565,"eighty":-9.640082,"marketCap":227755209},{"date":"2022-08-12","current":-2.63865,"twenty":-28.184862,"median":-17.350529,"eighty":-9.399025,"marketCap":247040932},{"date":"2022-08-19","current":-2.005962,"twenty":-28.113568,"median":-17.325491,"eighty":-9.25371,"marketCap":187806211},{"date":"2022-08-26","current":-1.731307,"twenty":-27.980942,"median":-17.222783,"eighty":-9.108998,"marketCap":162091913},{"date":"2022-09-02","current":-1.569457,"twenty":-27.842471,"median":-17.184059,"eighty":-8.95975,"marketCap":146938844},{"date":"2022-09-09","current":-1.682262,"twenty":-27.794038,"median":-17.149824,"eighty":-8.761414,"marketCap":157500074},{"date":"2022-09-16","current":-1.731307,"twenty":-27.782118,"median":-17.095171,"eighty":-8.561169,"marketCap":162091913},{"date":"2022-09-23","current":-1.510602,"twenty":-27.741229,"median":-17.007268,"eighty":-8.357076,"marketCap":141428638},{"date":"2022-09-30","current":-1.456652,"twenty":-27.608552,"median":-16.923093,"eighty":-7.947355,"marketCap":136377615},{"date":"2022-10-07","current":-1.54003,"twenty":-27.432781,"median":-16.883515,"eighty":-7.773533,"marketCap":144183741},{"date":"2022-10-14","current":-1.186902,"twenty":-27.30957,"median":-16.755342,"eighty":-7.379578,"marketCap":111122501},{"date":"2022-10-21","current":-1.142761,"twenty":-27.243815,"median":-16.728928,"eighty":-7.174409,"marketCap":106989846},{"date":"2022-10-28","current":-1.309516,"twenty":-27.223296,"median":-16.694785,"eighty":-6.954842,"marketCap":122602098},{"date":"2022-11-04","current":-1.135306,"twenty":-27.175377,"median":-16.530112,"eighty":-6.759792,"marketCap":116307528},{"date":"2022-11-11","current":-1.238515,"twenty":-27.126227,"median":-16.481316,"eighty":-6.236753,"marketCap":126880939},{"date":"2022-11-18","current":-1.045558,"twenty":-27.080841,"median":-16.444905,"eighty":-5.977635,"marketCap":107113257},{"date":"2022-11-25","current":-1.14428,"twenty":-27.065227,"median":-16.430704,"eighty":-5.783297,"marketCap":117226955},{"date":"2022-12-02","current":-1.287876,"twenty":-27.046946,"median":-16.324964,"eighty":-5.685438,"marketCap":131937788},{"date":"2022-12-09","current":-1.090432,"twenty":-26.974864,"median":-16.175084,"eighty":-5.563846,"marketCap":111710392},{"date":"2022-12-16","current":-0.964785,"twenty":-26.952059,"median":-16.011771,"eighty":-5.259547,"marketCap":98838413},{"date":"2022-12-23","current":-0.875038,"twenty":-26.910207,"median":-15.893487,"eighty":-5.14709,"marketCap":89644142},{"date":"2022-12-30","current":-0.8885,"twenty":-26.895174,"median":-15.823015,"eighty":-4.710661,"marketCap":91023282},{"date":"2023-01-06","current":-1.018634,"twenty":-26.886637,"median":-15.782689,"eighty":-4.261763,"marketCap":104354975},{"date":"2023-01-13","current":-1.287876,"twenty":-26.839913,"median":-15.69763,"eighty":-4.015146,"marketCap":131937788},{"date":"2023-01-20","current":-0.964785,"twenty":-26.825454,"median":-15.633234,"eighty":-3.908463,"marketCap":98838413},{"date":"2023-01-27","current":-1.067995,"twenty":-26.816597,"median":-15.531066,"eighty":-2.876083,"marketCap":109411824},{"date":"2023-02-03","current":-1.750076,"twenty":-26.789907,"median":-15.50053,"eighty":-2.626879,"marketCap":179288284},{"date":"2023-02-10","current":-1.584043,"twenty":-26.775068,"median":-15.479229,"eighty":-2.491334,"marketCap":162278883},{"date":"2023-02-17","current":-1.507758,"twenty":-26.748364,"median":-15.429524,"eighty":-2.452073,"marketCap":154463752},{"date":"2023-02-24","current":-1.216729,"twenty":-26.695368,"median":-15.354274,"eighty":-2.433245,"marketCap":137873648},{"date":"2023-03-03","current":-1.158986,"twenty":-26.637364,"median":-15.301238,"eighty":-2.347319,"marketCap":131330492},{"date":"2023-03-10","current":-1.066185,"twenty":-26.625121,"median":-15.24491,"eighty":-2.316346,"marketCap":120814705},{"date":"2023-03-17","current":-1.12599,"twenty":-26.604035,"median":-15.109999,"eighty":-2.277086,"marketCap":127591545},{"date":"2023-03-24","current":-1.072371,"twenty":-26.538512,"median":-14.953501,"eighty":-2.262504,"marketCap":121515758},{"date":"2023-03-31","current":-1.138363,"twenty":-26.455812,"median":-14.882781,"eighty":-2.218515,"marketCap":128993650},{"date":"2023-04-06","current":-1.110386,"twenty":-26.43039,"median":-14.834076,"eighty":-2.199202,"marketCap":125823378},{"date":"2023-04-14","current":-1.316777,"twenty":-26.420983,"median":-14.754971,"eighty":-2.192957,"marketCap":149210623},{"date":"2023-04-21","current":-1.015446,"twenty":-26.377614,"median":-14.753186,"eighty":-2.14921,"marketCap":115065245},{"date":"2023-04-28","current":-0.941145,"twenty":-26.351099,"median":-14.648826,"eighty":-2.105463,"marketCap":106645837},{"date":"2023-05-05","current":-0.945645,"twenty":-26.334236,"median":-14.570356,"eighty":-2.069568,"marketCap":107581327},{"date":"2023-05-12","current":-0.859474,"twenty":-26.30131,"median":-14.542445,"eighty":-2.037039,"marketCap":97778052},{"date":"2023-05-19","current":-0.830688,"twenty":-26.282022,"median":-14.48515,"eighty":-1.986344,"marketCap":94503189},{"date":"2023-05-26","current":-0.797789,"twenty":-26.257354,"median":-14.275489,"eighty":-1.913289,"marketCap":90760488},{"date":"2023-06-02","current":-0.789565,"twenty":-26.209985,"median":-14.24373,"eighty":-1.906919,"marketCap":89824813},{"date":"2023-06-09","current":-0.875923,"twenty":-26.200403,"median":-14.156264,"eighty":-1.871235,"marketCap":99649402},{"date":"2023-06-16","current":-0.884148,"twenty":-26.192135,"median":-14.099821,"eighty":-1.834007,"marketCap":100585077},{"date":"2023-06-23","current":-0.843025,"twenty":-26.167063,"median":-14.055221,"eighty":-1.782314,"marketCap":95906701},{"date":"2023-06-30","current":-0.777228,"twenty":-26.140027,"median":-13.98811,"eighty":-1.737183,"marketCap":88421300},{"date":"2023-07-07","current":-0.740217,"twenty":-26.115937,"median":-13.889767,"eighty":-1.704332,"marketCap":84210762},{"date":"2023-07-14","current":-0.900597,"twenty":-26.088552,"median":-13.831898,"eighty":-1.673434,"marketCap":102456427},{"date":"2023-07-21","current":-0.884148,"twenty":-26.068089,"median":-13.789437,"eighty":-1.618636,"marketCap":100585077},{"date":"2023-07-28","current":-0.871811,"twenty":-26.062638,"median":-13.775093,"eighty":-1.588018,"marketCap":99181564},{"date":"2023-08-04","current":-0.838912,"twenty":-26.055704,"median":-13.739591,"eighty":-1.567439,"marketCap":95438864},{"date":"2023-08-11","current":-0.832285,"twenty":-26.045751,"median":-13.661484,"eighty":-1.536743,"marketCap":91696163},{"date":"2023-08-18","current":-0.775076,"twenty":-26.029347,"median":-13.515604,"eighty":-1.508896,"marketCap":85393265},{"date":"2023-08-25","current":-0.678192,"twenty":-25.997072,"median":-13.356224,"eighty":-1.444881,"marketCap":74719107},{"date":"2023-09-01","current":-0.801499,"twenty":-25.966661,"median":-13.291429,"eighty":-1.377616,"marketCap":88304399},{"date":"2023-09-07","current":-0.704615,"twenty":-25.959908,"median":-13.278443,"eighty":-1.345739,"marketCap":77630241},{"date":"2023-09-15","current":-0.612134,"twenty":-25.917593,"median":-13.196999,"eighty":-1.31574,"marketCap":67441272},{"date":"2023-09-22","current":-0.568096,"twenty":-25.864499,"median":-13.150244,"eighty":-1.309516,"marketCap":62589382},{"date":"2023-09-29","current":-0.524057,"twenty":-25.827636,"median":-13.124703,"eighty":-1.294802,"marketCap":57737492},{"date":"2023-10-06","current":-0.528461,"twenty":-25.802558,"median":-13.069481,"eighty":-1.275953,"marketCap":58222681},{"date":"2023-10-13","current":-0.466807,"twenty":-25.768806,"median":-13.000657,"eighty":-1.260952,"marketCap":51430035},{"date":"2023-10-20","current":-0.471211,"twenty":-25.705667,"median":-12.85202,"eighty":-1.245601,"marketCap":51915224},{"date":"2023-10-27","current":-0.444788,"twenty":-25.691685,"median":-12.800641,"eighty":-1.243951,"marketCap":49004090},{"date":"2023-11-03","current":-0.510846,"twenty":-25.64079,"median":-12.781014,"eighty":-1.230438,"marketCap":56281925},{"date":"2023-11-10","current":-0.404396,"twenty":-25.565043,"median":-12.660305,"eighty":-1.211591,"marketCap":45607766},{"date":"2023-11-17","current":-0.447795,"twenty":-25.487727,"median":-12.624802,"eighty":-1.196106,"marketCap":50502337},{"date":"2023-11-24","current":-0.686909,"twenty":-25.412698,"median":-12.6035,"eighty":-1.185114,"marketCap":77469605},{"date":"2023-12-01","current":-0.665171,"twenty":-25.390974,"median":-12.53568,"eighty":-1.162379,"marketCap":75018035},{"date":"2023-12-08","current":-0.643434,"twenty":-25.366632,"median":-12.482791,"eighty":-1.155047,"marketCap":72566466},{"date":"2023-12-15","current":-0.647781,"twenty":-25.296407,"median":-12.477512,"eighty":-1.146612,"marketCap":73056780},{"date":"2023-12-22","current":-0.656476,"twenty":-25.24059,"median":-12.467291,"eighty":-1.138649,"marketCap":74037407},{"date":"2023-12-29","current":-1.021669,"twenty":-25.153869,"median":-12.426882,"eighty":-1.137752,"marketCap":115223780},{"date":"2024-01-05","current":-0.869505,"twenty":-25.109488,"median":-12.397584,"eighty":-1.128126,"marketCap":98062792},{"date":"2024-01-12","current":-0.786902,"twenty":-25.053574,"median":-12.291075,"eighty":-1.11751,"marketCap":88746826},{"date":"2024-01-19","current":-0.704299,"twenty":-24.991298,"median":-12.127762,"eighty":-1.111212,"marketCap":79430861},{"date":"2024-01-26","current":-0.652129,"twenty":-24.929895,"median":-11.807214,"eighty":-1.106192,"marketCap":73547094},{"date":"2024-02-02","current":-0.560831,"twenty":-24.878907,"median":-11.774961,"eighty":-1.091121,"marketCap":63250500},{"date":"2024-02-09","current":-0.508661,"twenty":-24.807149,"median":-11.637823,"eighty":-1.077321,"marketCap":57366733},{"date":"2024-02-16","current":-0.573873,"twenty":-24.74565,"median":-11.435609,"eighty":-1.066547,"marketCap":64721442},{"date":"2024-02-23","current":-0.543441,"twenty":-24.567517,"median":-11.313357,"eighty":-1.05902,"marketCap":61289245},{"date":"2024-03-01","current":-0.722843,"twenty":-24.535707,"median":-11.140722,"eighty":-1.045558,"marketCap":78281027},{"date":"2024-03-08","current":-0.783469,"twenty":-24.482692,"median":-11.079458,"eighty":-1.044528,"marketCap":84846533},{"date":"2024-03-15","current":-0.736834,"twenty":-24.467892,"median":-10.971923,"eighty":-1.032096,"marketCap":79796144},{"date":"2024-03-22","current":-0.680872,"twenty":-24.40847,"median":-10.906129,"eighty":-1.018634,"marketCap":73735677},{"date":"2024-03-28","current":-0.676208,"twenty":-24.399987,"median":-10.865328,"eighty":-1.007353,"marketCap":73230639},{"date":"2024-04-05","current":-0.662017,"twenty":-24.372497,"median":-10.803124,"eighty":-0.990812,"marketCap":71693759},{"date":"2024-04-12","current":-0.647831,"twenty":-24.363931,"median":-10.718725,"eighty":-0.977432,"marketCap":70157464},{"date":"2024-04-19","current":-0.572172,"twenty":-24.358158,"median":-10.580617,"eighty":-0.963359,"marketCap":61963891},{"date":"2024-04-26","current":-0.591086,"twenty":-24.30648,"median":-10.476588,"eighty":-0.949945,"marketCap":64012285},{"date":"2024-05-03","current":-0.75659,"twenty":-24.289061,"median":-10.41444,"eighty":-0.941145,"marketCap":81935724},{"date":"2024-05-10","current":-0.912437,"twenty":-24.248626,"median":-10.364249,"eighty":-0.929501,"marketCap":84496216},{"date":"2024-05-17","current":-0.771424,"twenty":-24.167648,"median":-10.304401,"eighty":-0.92019,"marketCap":71437710},{"date":"2024-05-24","current":-0.807645,"twenty":-24.145233,"median":-10.235347,"eighty":-0.908682,"marketCap":74791928},{"date":"2024-05-31","current":-0.734732,"twenty":-24.130941,"median":-10.13456,"eighty":-0.903941,"marketCap":68039879},{"date":"2024-06-07","current":-0.78521,"twenty":-24.116805,"median":-10.07422,"eighty":-0.900597,"marketCap":72714374},{"date":"2024-06-14","current":-0.762775,"twenty":-24.112102,"median":-10.028184,"eighty":-0.894017,"marketCap":70636821},{"date":"2024-06-21","current":-0.689863,"twenty":-24.090375,"median":-9.91909,"eighty":-0.88826,"marketCap":63884771},{"date":"2024-06-28","current":-0.678646,"twenty":-23.520394,"median":-9.882404,"eighty":-0.884148,"marketCap":62845995},{"date":"2024-07-05","current":-0.667429,"twenty":-23.397545,"median":-9.598851,"eighty":-0.877364,"marketCap":61807218},{"date":"2024-07-12","current":-0.953469,"twenty":-23.219289,"median":-9.391352,"eighty":-0.871944,"marketCap":88296026},{"date":"2024-07-15","current":-0.931035,"twenty":-23.114861,"median":-9.287537,"eighty":-0.871944,"marketCap":86218472},{"date":"2024-08-02","current":-2.002286,"twenty":-22.416979,"median":-9.023064,"eighty":-0.869111,"marketCap":185421655},{"date":"2024-08-09","current":-2.235012,"twenty":-22.204067,"median":-8.765055,"eighty":-0.869111,"marketCap":182046214},{"date":"2024-08-16","current":-3.303648,"twenty":-21.925378,"median":-8.552055,"eighty":-0.869111,"marketCap":269088718},{"date":"2024-08-23","current":-3.974589,"twenty":-21.482775,"median":-8.067816,"eighty":-0.869111,"marketCap":323738185},{"date":"2024-08-30","current":-4.037235,"twenty":-21.314958,"median":-7.803109,"eighty":-0.869111,"marketCap":328840889},{"date":"2024-09-06","current":-3.591747,"twenty":-21.212444,"median":-7.504703,"eighty":-0.869111,"marketCap":292554997},{"date":"2024-09-13","current":-3.98851,"twenty":-21.08766,"median":-7.178669,"eighty":-0.869111,"marketCap":324872119},{"date":"2024-09-20","current":-4.127725,"twenty":-20.928285,"median":-6.901777,"eighty":-0.869111,"marketCap":336211460},{"date":"2024-09-27","current":-3.591747,"twenty":-20.642705,"median":-6.467617,"eighty":-0.869111,"marketCap":292554997},{"date":"2024-10-04","current":-3.362042,"twenty":-20.322218,"median":-6.035388,"eighty":-0.869111,"marketCap":273845085},{"date":"2024-10-11","current":-3.438611,"twenty":-20.111407,"median":-5.762421,"eighty":-0.869111,"marketCap":280081722},{"date":"2024-10-18","current":-3.215867,"twenty":-20.084717,"median":-5.623416,"eighty":-0.869111,"marketCap":261938777},{"date":"2024-10-25","current":-3.271553,"twenty":-20.084717,"median":-5.416672,"eighty":-0.869111,"marketCap":266474513},{"date":"2024-10-31","current":-3.612629,"twenty":-20.084717,"median":-5.17851,"eighty":-0.869111,"marketCap":294255898},{"date":"2024-11-08","current":-2.678497,"twenty":-20.09065,"median":-4.648314,"eighty":-0.868883,"marketCap":244929765},{"date":"2024-11-15","current":-2.666096,"twenty":-20.09065,"median":-4.16949,"eighty":-0.868883,"marketCap":243795831},{"date":"2024-11-22","current":-2.611359,"twenty":-20.09065,"median":-4.065078,"eighty":-0.868883,"marketCap":238790523},{"date":"2024-11-29","current":-3.067188,"twenty":-20.09065,"median":-4.017917,"eighty":-0.868883,"marketCap":280472893},{"date":"2024-12-06","current":-2.920396,"twenty":-20.09065,"median":-3.98851,"eighty":-0.868883,"marketCap":267049757},{"date":"2024-12-13","current":-2.765878,"twenty":-20.09065,"median":-3.946746,"eighty":-0.868883,"marketCap":252920140},{"date":"2024-12-20","current":-4.063831,"twenty":-20.09065,"median":-3.879368,"eighty":-0.868883,"marketCap":371608921},{"date":"2024-12-27","current":-4.836423,"twenty":-20.09065,"median":-3.879368,"eighty":-0.868883,"marketCap":442257005},{"date":"2025-01-03","current":-4.844149,"twenty":-20.09065,"median":-3.879368,"eighty":-0.868883,"marketCap":442963486},{"date":"2025-01-10","current":-4.326512,"twenty":-20.096584,"median":-3.864332,"eighty":-0.868654,"marketCap":395629270},{"date":"2025-01-17","current":-3.712422,"twenty":-20.096584,"median":-3.845815,"eighty":-0.868654,"marketCap":339475012},{"date":"2025-01-24","current":-4.776443,"twenty":-20.096584,"median":-3.842334,"eighty":-0.868654,"marketCap":436772243},{"date":"2025-01-31","current":-4.162883,"twenty":-20.096584,"median":-3.842334,"eighty":-0.868654,"marketCap":380666540},{"date":"2025-02-07","current":-4.007552,"twenty":-20.096584,"median":-3.820094,"eighty":-0.868654,"marketCap":366462565},{"date":"2025-02-14","current":-3.87552,"twenty":-20.096584,"median":-3.792251,"eighty":-0.868654,"marketCap":354389186},{"date":"2025-02-21","current":-4.217249,"twenty":-20.096584,"median":-3.792251,"eighty":-0.868654,"marketCap":385637932},{"date":"2025-02-28","current":-3.293027,"twenty":-20.096584,"median":-3.710481,"eighty":-0.868654,"marketCap":301124278},{"date":"2025-03-07","current":-4.582341,"twenty":-20.102517,"median":-3.708539,"eighty":-0.868426,"marketCap":372470995},{"date":"2025-03-14","current":-3.87653,"twenty":-20.102517,"median":-3.708539,"eighty":-0.868426,"marketCap":315099870},{"date":"2025-03-21","current":-3.919965,"twenty":-20.102517,"median":-3.708539,"eighty":-0.868426,"marketCap":318630401},{"date":"2025-03-28","current":-3.887389,"twenty":-20.102517,"median":-3.708539,"eighty":-0.868426,"marketCap":315982503},{"date":"2025-04-04","current":-3.583347,"twenty":-20.102517,"median":-3.703119,"eighty":-0.868426,"marketCap":291268787},{"date":"2025-04-11","current":-3.290164,"twenty":-20.096584,"median":-3.630032,"eighty":-0.868654,"marketCap":267437705},{"date":"2025-04-17","current":-3.572488,"twenty":-20.096584,"median":-3.605669,"eighty":-0.868654,"marketCap":290386155},{"date":"2025-04-25","current":-4.158854,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":338048320},{"date":"2025-05-02","current":-4.19143,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":340696218},{"date":"2025-05-09","current":-5.41763,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":455438468},{"date":"2025-05-16","current":-5.137748,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":431909924},{"date":"2025-05-23","current":-4.854069,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":408062137},{"date":"2025-05-30","current":-4.822549,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":405412383},{"date":"2025-06-06","current":-5.316361,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":446925198},{"date":"2025-06-13","current":-6.104359,"twenty":-20.102517,"median":-3.591747,"eighty":-0.868426,"marketCap":513169051},{"date":"2025-06-20","current":-6.860837,"twenty":-20.108451,"median":-3.587547,"eighty":-0.868197,"marketCap":576763151},{"date":"2025-06-27","current":-6.692731,"twenty":-20.108451,"median":-3.587547,"eighty":-0.868197,"marketCap":562631129},{"date":"2025-07-03","current":-7.827448,"twenty":-20.108451,"median":-3.587547,"eighty":-0.868197,"marketCap":658022278},{"date":"2025-07-11","current":-7.270596,"twenty":-20.108451,"median":-3.587547,"eighty":-0.868197,"marketCap":611209954},{"date":"2025-07-18","current":-6.808304,"twenty":-20.108451,"median":-3.587547,"eighty":-0.868197,"marketCap":572346894},{"date":"2025-07-25","current":-7.049957,"twenty":-20.108451,"median":-3.587547,"eighty":-0.868197,"marketCap":592661675},{"date":"2025-08-01","current":-5.75764,"twenty":-20.078783,"median":-3.587547,"eighty":-0.868197,"marketCap":484021756},{"date":"2025-08-08","current":-4.413461,"twenty":-19.674739,"median":-3.587547,"eighty":-0.868197,"marketCap":403037246},{"date":"2025-08-15","current":-4.525133,"twenty":-19.457883,"median":-3.587547,"eighty":-0.868197,"marketCap":413235108},{"date":"2025-08-22","current":-4.525133,"twenty":-19.07572,"median":-3.587547,"eighty":-0.868197,"marketCap":413235108},{"date":"2025-08-29","current":-4.64166,"twenty":-18.722138,"median":-3.587547,"eighty":-0.868197,"marketCap":423876356},{"date":"2025-09-05","current":-4.942688,"twenty":-18.361485,"median":-3.583347,"eighty":-0.867644,"marketCap":451366245},{"date":"2025-09-12","current":-5.923457,"twenty":-18.200606,"median":-3.587547,"eighty":-0.868197,"marketCap":540930078},{"date":"2025-09-19","current":-5.65156,"twenty":-17.74095,"median":-3.587547,"eighty":-0.868197,"marketCap":516100500},{"date":"2025-09-26","current":-5.80693,"twenty":-17.519961,"median":-3.587547,"eighty":-0.868197,"marketCap":530288830},{"date":"2025-10-03","current":-6.574066,"twenty":-17.245936,"median":-3.587547,"eighty":-0.868197,"marketCap":600343709},{"date":"2025-10-10","current":-8.360814,"twenty":-17.077984,"median":-3.587547,"eighty":-0.868197,"marketCap":763509503},{"date":"2025-10-17","current":-9.982481,"twenty":-16.883515,"median":-3.587547,"eighty":-0.868197,"marketCap":911600197},{"date":"2025-10-24","current":-9.176503,"twenty":-16.494575,"median":-3.587547,"eighty":-0.868197,"marketCap":837998235},{"date":"2025-10-31","current":-9.234766,"twenty":-16.194031,"median":-3.587547,"eighty":-0.868197,"marketCap":843318859},{"date":"2025-11-07","current":-8.636076,"twenty":-15.744326,"median":-3.587547,"eighty":-0.868197,"marketCap":638059240},{"date":"2025-11-14","current":-9.13489,"twenty":-15.301238,"median":-3.587547,"eighty":-0.868197,"marketCap":674913044},{"date":"2025-11-21","current":-9.952222,"twenty":-14.110047,"median":-3.587547,"eighty":-0.868197,"marketCap":735300001},{"date":"2025-11-28","current":-12.897022,"twenty":-12.897022,"median":-3.587547,"eighty":-0.868197,"marketCap":952870654},{"date":"2025-12-05","current":-12.596532,"twenty":-12.139787,"median":-3.587547,"eighty":-0.868197,"marketCap":930669567},{"date":"2025-12-12","current":-11.154181,"twenty":-11.634965,"median":-3.587547,"eighty":-0.868197,"marketCap":824104349},{"date":"2025-12-19","current":-9.525526,"twenty":-11.217449,"median":-3.587547,"eighty":-0.868197,"marketCap":703774457},{"date":"2025-12-26","current":-10.108476,"twenty":-11.133049,"median":-3.587547,"eighty":-0.868197,"marketCap":746844566},{"date":"2026-01-02","current":-9.567595,"twenty":-10.948905,"median":-3.587547,"eighty":-0.868197,"marketCap":706882610},{"date":"2026-01-09","current":-10.066408,"twenty":-10.84916,"median":-3.587547,"eighty":-0.868197,"marketCap":743736414},{"date":"2026-01-16","current":-11.550827,"twenty":-10.70338,"median":-3.587547,"eighty":-0.868197,"marketCap":853409784},{"date":"2026-01-23","current":-13.52204,"twenty":-10.70338,"median":-3.587547,"eighty":-0.868197,"marketCap":999048915},{"date":"2026-01-30","current":-11.983533,"twenty":-10.70338,"median":-3.587547,"eighty":-0.868197,"marketCap":885379349},{"date":"2026-02-06","current":-8.912527,"twenty":-10.580617,"median":-3.587547,"eighty":-0.868197,"marketCap":658484240},{"date":"2026-02-13","current":-10.084437,"twenty":-10.493103,"median":-3.587547,"eighty":-0.868197,"marketCap":745068479},{"date":"2026-02-20","current":-10.709456,"twenty":-10.481084,"median":-3.587547,"eighty":-0.868197,"marketCap":791246740},{"date":"2026-02-27","current":-9.86715,"twenty":-10.319746,"median":-3.587547,"eighty":-0.868197,"marketCap":801903262},{"date":"2026-03-06","current":-11.020653,"twenty":-10.319746,"median":-3.587547,"eighty":-0.868197,"marketCap":895648481},{"date":"2026-03-13","current":-8.484358,"twenty":-10.30079,"median":-3.587547,"eighty":-0.868197,"marketCap":689523772},{"date":"2026-03-20","current":-9.256834,"twenty":-10.192614,"median":-3.587547,"eighty":-0.868197,"marketCap":752302872},{"date":"2026-03-27","current":-9.424203,"twenty":-10.104911,"median":-3.587547,"eighty":-0.868197,"marketCap":765905010},{"date":"2026-04-02","current":-8.445734,"twenty":-10.066408,"median":-3.587547,"eighty":-0.868197,"marketCap":686384817},{"date":"2026-04-10","current":-7.84408,"twenty":-9.988281,"median":-3.587547,"eighty":-0.868197,"marketCap":637488411},{"date":"2026-04-17","current":-8.578255,"twenty":-9.952222,"median":-3.587547,"eighty":-0.868197,"marketCap":697154814},{"date":"2026-04-24","current":-7.599355,"twenty":-9.882404,"median":-3.587547,"eighty":-0.868197,"marketCap":617599610},{"date":"2026-05-01","current":-7.109905,"twenty":-9.783947,"median":-3.587547,"eighty":-0.868197,"marketCap":577822008},{"date":"2026-05-08","current":-7.715278,"twenty":-9.627693,"median":-3.587547,"eighty":-0.868197,"marketCap":627020621},{"date":"2026-05-15","current":-7.353887,"twenty":-9.531536,"median":-3.587547,"eighty":-0.868197,"marketCap":702678567},{"date":"2026-05-22","current":-9.041664,"twenty":-9.41134,"median":-3.587547,"eighty":-0.868197,"marketCap":863949058},{"date":"2026-05-29","current":-12.033633,"twenty":-9.399846,"median":-3.583347,"eighty":-0.867644,"marketCap":1149837656},{"date":"2026-06-05","current":-13.261107,"twenty":-9.399846,"median":-3.587547,"eighty":-0.868197,"marketCap":1267125285},{"date":"2026-06-12","current":-10.323936,"twenty":-9.399846,"median":-3.587547,"eighty":-0.868197,"marketCap":986472743},{"date":"2026-06-18","current":-10.685603,"twenty":-9.399846,"median":-3.587547,"eighty":-0.868197,"marketCap":1021030705},{"date":"2026-06-26","current":-13.798127,"twenty":-9.399846,"median":-3.583347,"eighty":-0.867644,"marketCap":1318438623},{"date":"2026-07-02","current":-15.113278,"twenty":-9.399846,"median":-3.583347,"eighty":-0.867644,"marketCap":1444103941},{"date":"2026-07-10","current":-16.055803,"twenty":-9.399846,"median":-3.583347,"eighty":-0.867644,"marketCap":1534164085},{"date":"2026-07-17","current":-17.075045,"twenty":-9.399846,"median":-3.583347,"eighty":-0.867644,"marketCap":1631554706},{"date":"2026-07-24","current":-13.392622,"twenty":-9.399846,"median":-3.583347,"eighty":-0.867644,"marketCap":1279691817},{"date":"2026-07-31","current":-13.45838,"twenty":-9.399353,"median":-3.577917,"eighty":-0.867091,"marketCap":1285975083},{"date":"2026-08-07","current":-12.983909,"twenty":-9.399353,"median":-3.577917,"eighty":-0.867091,"marketCap":1391602332},{"date":"2026-08-14","current":-14.368992,"twenty":-9.399353,"median":-3.577917,"eighty":-0.867091,"marketCap":1540054154},{"date":"2026-08-21","current":-16.82029,"twenty":-9.399353,"median":-3.577917,"eighty":-0.867091,"marketCap":1802781839}],"updateTime":1787456466115},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSNL\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647307223","title":"Personalis Cfo/coo Aaron Tachibana Disposes of 4,982 Common Shares for $69,748","url":"https://stock-news.laohu8.com/highlight/detail?id=2647307223","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647307223?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:51","pubTimestamp":1782769888,"startTime":"0","endTime":"0","summary":"Personalis CFO/COO Aaron Tachibana disposes of 4,982 common shares for $69,748Aaron Tachibana, CFO and COO, exercised stock options for 4,982 shares at $5.32 on June 29, 2026.He sold 4,982 shares at $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL9p9Fqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Personalis Cfo/coo Aaron Tachibana Disposes of 4,982 Common Shares for $69,748","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646171395","title":"Personalis CEO Christopher M. Hall Disposes of 100,000 Common Shares Worth $1.32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2646171395","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646171395?lang=en_us&edition=fundamental","pubTime":"2026-06-27 07:50","pubTimestamp":1782517841,"startTime":"0","endTime":"0","summary":"Personalis CEO Christopher M. Hall disposes of 100,000 common shares worth $1.32 millionPersonalis CEO Christopher M. Hall sold 100,000 common shares on June 26, 2026 at a weighted-average price of US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL8W99QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Personalis CEO Christopher M. Hall Disposes of 100,000 Common Shares Worth $1.32 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644795433","title":"Personalis (PSNL) Stock Could Be 10% Undervalued After ASCO Cancer Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644795433?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:26","pubTimestamp":1781648772,"startTime":"0","endTime":"0","summary":"Personalis (PSNL) stock is in focus after the company released new clinical data at the 2026 ASCO meeting, highlighting how its NeXT Personal test detects minimal residual disease across six solid tumor types.\nSee our latest analysis for Personalis.\nThe ASCO update comes after a sharp 53.93% 1 month share price return and a 37.50% 3 month share price return. The 1 year total shareholder return of 51.78% and very large 3 year total shareholder return indicate that momentum has been strong...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-psnl-stock-could-be-10-undervalued-after-asco-can","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-psnl-stock-could-be-10-undervalued-after-asco-can","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643220463","title":"How Investors May Respond To Personalis (PSNL) CE Mark Win For Its MRD Blood Collection Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=2643220463","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643220463?lang=en_us&edition=fundamental","pubTime":"2026-06-15 14:18","pubTimestamp":1781504282,"startTime":"0","endTime":"0","summary":"Earlier this month, Personalis announced clinical data from the 2026 ASCO meeting showing its NeXT Personal assay can detect minimal residual disease at ultra-low levels across six solid tumor types, with strong correlations to relapse and progression risk in colorectal, lung, ovarian, endometrial, melanoma, and renal cancers.\nShortly afterward, the company received CE Mark Class A approval for its EDTA and cfDNA Blood Collection Kits, opening the door for broader use of its MRD ecosystem in...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/how-investors-may-respond-to-personalis-psnl-ce-mark-win-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/how-investors-may-respond-to-personalis-psnl-ce-mark-win-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSNL","BK4109","BK4211","BK4588","BK4121","CE","BK4585","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642493705","title":"A Look At Personalis (PSNL) Valuation After New ASCO Data On NeXT Personal MRD Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2642493705","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642493705?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:19","pubTimestamp":1781011173,"startTime":"0","endTime":"0","summary":"ASCO data puts NeXT Personal in focus\nPersonalis (PSNL) is back in the spotlight after releasing new clinical data at the 2026 ASCO Annual Meeting on its NeXT Personal platform for ultrasensitive minimal residual disease detection across six solid tumor types.\nFor you as an investor, the key takeaway is that ASCO collaborators reported early relapse detection ahead of imaging, sensitivity at very low ctDNA levels, and links between molecular clearance and future recurrence or progression...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/a-look-at-personalis-psnl-valuation-after-new-asco-data-on-n","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/a-look-at-personalis-psnl-valuation-after-new-asco-data-on-n","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSNL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642785464","title":"Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642785464","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642785464?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:09","pubTimestamp":1781003394,"startTime":"0","endTime":"0","summary":"Personalis  said Tuesday its two blood collection kits have received European regulatory approval under the EU In Vitro Diagnostic Regulation.The company said the approval allows its EDTA Blood Collection Kit and cfDNA Blood Collection Kit to be used in clinical studies across the EU and Great Britain.The kits are designed to preserve blood sample quality for advanced genomic testing, including detection of minimal residual disease using its NeXT Personal test, it added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PSNL","BK4156","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642693044","title":"Personalis blood collection kits win EU CE-IVD mark under IVDR","url":"https://stock-news.laohu8.com/highlight/detail?id=2642693044","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642693044?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:00","pubTimestamp":1780999253,"startTime":"0","endTime":"0","summary":"Personalis obtained Class A CE-IVD marking under the EU IVDR for its EDTA blood collection kit and cfDNA blood collection kit.The clearance enables use of the kits at clinical trial sites across the EU and Great Britain, supporting global deployment of its NeXT Personal MRD test.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL2wwPcr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641029179","title":"Can Personalis (PSNL) Turn NeXT Personal’s Multi‑Tumor MRD Data Into Durable Competitive Advantage?","url":"https://stock-news.laohu8.com/highlight/detail?id=2641029179","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641029179?lang=en_us&edition=fundamental","pubTime":"2026-06-08 05:23","pubTimestamp":1780867387,"startTime":"0","endTime":"0","summary":"In early June 2026, Personalis reported new clinical data from the ASCO Annual Meeting showing its NeXT Personal liquid biopsy test can detect minimal residual disease across six major solid tumors at ultra-low circulating tumor DNA levels, often well before imaging. \nThe breadth of evidence, ranging from colorectal and lung cancer to ovarian, endometrial, melanoma, and renal cell carcinoma, highlights NeXT Personal’s potential to inform earlier, less invasive treatment decisions across...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/can-personalis-psnl-turn-next-personals-multitumor-mrd-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/can-personalis-psnl-turn-next-personals-multitumor-mrd-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641012375","title":"Personalis CFO, COO Aaron Tachibana disposes of common shares worth $480,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2641012375","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641012375?lang=en_us&edition=fundamental","pubTime":"2026-06-06 08:20","pubTimestamp":1780705213,"startTime":"0","endTime":"0","summary":"Personalis CFO and COO Aaron Tachibana sold 40,000 common shares at USD 12.01 on June 4, 2026.He exercised stock options for 40,000 shares at USD 9.16 the same day.His direct common stock holdings fell to 198,833 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260606:nNDL4GghMt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Personalis CFO, COO Aaron Tachibana disposes of common shares worth $480,400","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSNL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640100999","title":"Personalis' Cancer Monitoring Tool Shows Early Detection of Relapse","url":"https://stock-news.laohu8.com/highlight/detail?id=2640100999","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640100999?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:03","pubTimestamp":1780401812,"startTime":"0","endTime":"0","summary":"Personalis'  ultrasensitive minimal residual disease detection with NeXT Personal showed early detection of patients at risk for relapse across six solid tumor types, the company said Tuesday.The tool successfully identified all instances of colorectal cancer relapse before clinical imaging and detected 82% of future relapses four weeks after surgery, the company said.NeXT Personal also consistently identified genetic tumor material at extremely low levels in lung cancer patients, predicting a higher risk of disease return, it said.Additional studies covering ovarian and endometrial cancers, melanoma, and renal cell carcinoma indicated that the test can forecast treatment responses and potential relapses, Personalis said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640753911","title":"Personalis NeXT Personal MRD test posts 100% sensitivity for colorectal cancer relapse in VICTORI study at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640753911","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640753911?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:01","pubTimestamp":1780394485,"startTime":"0","endTime":"0","summary":"Personalis highlighted clinical data already presented at ASCO 2026 on its NeXT Personal MRD blood test across multiple solid tumors.In a prospective colorectal cancer study, the test identified recurrence earlier than standard imaging, supporting use in post-surgery surveillance decisions.A lung cancer analysis showed the assay detected very low-level residual disease that correlated with higher relapse risk, pointing to earlier intervention opportunities.Additional ASCO presentations in ovarian, endometrial, and melanoma indicated ctDNA detection or clearance aligned with progression risk, supporting broader clinical adoption.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL7xH5Vg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639160354","title":"Personalis CEO Christopher M. Hall disposes of common shares worth $1,101,800.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2639160354","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639160354?lang=en_us&edition=fundamental","pubTime":"2026-05-30 08:45","pubTimestamp":1780101941,"startTime":"0","endTime":"0","summary":"Personalis CEO Christopher M. Hall sold 100,000 common shares on May 28-29 at a weighted average USD 11.02.Sales followed option exercises at USD 1.61, totaling 100,000 shares over the same two days.Hall’s direct common stock holding ended at 235,986 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL7BRJsq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","COLD","PSNL","BK4171","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639608069","title":"Personalis CFO, COO Aaron Tachibana disposes of common shares valued at $449,248.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2639608069","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639608069?lang=en_us&edition=fundamental","pubTime":"2026-05-30 08:27","pubTimestamp":1780100865,"startTime":"0","endTime":"0","summary":"Personalis CFO and COO Aaron Tachibana exercised stock options for 38,799 common shares at USD 9.16 on May 29, 2026.He sold 38,799 common shares at a weighted average USD 11.58 in the same transaction set.Directly held common shares fell to 198,833 from 237,632.Stock options held directly declined to 68,832, with the exercised options fully vested.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Personalis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL5sRPnM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Personalis CFO, COO Aaron Tachibana disposes of common shares valued at $449,248.42","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSNL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638138275","title":"Personalis NeXT Personal ctDNA assay posts 100% longitudinal sensitivity for colorectal cancer recurrence in VICTORI study","url":"https://stock-news.laohu8.com/highlight/detail?id=2638138275","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638138275?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:00","pubTimestamp":1779789647,"startTime":"0","endTime":"0","summary":"Personalis flagged six clinical abstracts on its NeXT Personal ctDNA test scheduled for the 2026 ASCO meeting in Chicago on May 29–June 2.Future TRACERx podium data in early-stage non-small cell lung cancer is set to show that ultra-low ctDNA detection identifies patients at high relapse risk.Future VICTORI colorectal cancer poster results are expected to show the test can detect recurrence early in post-surgery surveillance.Additional posters across other solid tumors are slated to support broader clinical use in relapse monitoring and treatment-response assessment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL7pLqX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637531453","title":"Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637531453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637531453?lang=en_us&edition=fundamental","pubTime":"2026-05-22 00:50","pubTimestamp":1779382215,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Personalis (PSNL), Eton Pharmaceuticals (ETON) and S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-personalis-psnl-eton-pharmaceuticals-eton-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-personalis-psnl-eton-pharmaceuticals-eton-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","LU0128526141.USD","BLSX","BLSG","PSNL","BK4121","LABU","LU0029874061.USD","BK4112","BK4007","BK4581","ETON","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878192","title":"Personalis Inc - CMS Expands Medicare Coverage for Personalis Next Personal Test in Breast Cancer Monitoring - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878192?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:13","pubTimestamp":1779308007,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X11I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636737847","title":"Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Personalis (PSNL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636737847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636737847?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:50","pubTimestamp":1779281406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM) and Personalis (PSNL) with bullish sen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-insmed-insm-personalis-psnl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-insmed-insm-personalis-psnl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","LU0889565916.HKD","XBI","LU0320765992.SGD","BK4585","LU0053671581.USD","BK4139","LU0029874061.USD","BLSX","INSM","BK4588","BK4112","LU0109394709.USD","PSNL","BLSG","LU0128526141.USD","BK4121","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636845204","title":"Personalis NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2636845204","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636845204?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:31","pubTimestamp":1779273104,"startTime":"0","endTime":"0","summary":"Personalis  said Wednesday its NeXT personal minimal residual disease test has been approved for expanded coverage by the US Centers for Medicare & Medicaid Services' Molecular Diagnostic Services Program.The approval is for monitoring treatment response to neoadjuvant therapy in patients diagnosed with Stage II-III triple-negative breast cancer or HER2-positive breast cancer, it said Wednesday.The coverage decision was backed by clinical evidence from a 227-patient study showing monitoring with NeXT allows accurate tracking of therapy response, outperforming standard clinical metrics, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PSNL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636845556","title":"Personalis secures fourth Medicare coverage decision for NeXT Personal","url":"https://stock-news.laohu8.com/highlight/detail?id=2636845556","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636845556?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:10","pubTimestamp":1779271856,"startTime":"0","endTime":"0","summary":"Personalis (PSNL) announced that the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program has expanded coverage for the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/personalis-secures-fourth-medicare-coverage-decision-for-next-personal-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/personalis-secures-fourth-medicare-coverage-decision-for-next-personal-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636341843","title":"Personalis cites PREDICT-DNA study supporting NeXT Personal monitoring in breast cancer NAT","url":"https://stock-news.laohu8.com/highlight/detail?id=2636341843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636341843?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:01","pubTimestamp":1779271318,"startTime":"0","endTime":"0","summary":"Personalis disclosed a new Medicare coverage determination that expands use of its NeXT Personal blood-based MRD test to monitor response to pre-surgical treatment in Stage II-III triple-negative or HER2-positive breast cancer.The clinical evidence supporting the move was already published from the prospective PREDICT-DNA study in the Journal of Clinical Oncology.Study findings indicated the test can track treatment response during neoadjuvant therapy and better anticipate longer-term outcomes than standard clinical assessments.The expanded reimbursement broadens the product’s addressable breast cancer use beyond post-surgery surveillance into active treatment management, a shift that can support higher utilization in eligible Medicare patients.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL1PMJTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PSNL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":134,"code":"91000000","status":"200"}]}}